Costes directos sanitarios en pacientes con diabetes mellitus tipo 2 a los seis meses de inicio del tratamiento con insulina en España: estudio INSTIGATE
Authors:
- Helen SmithHSHelen Smith
- Jesús ReviriegoJRJesús Reviriego
- Conxa CastellCCConxa Castell
- Alberto GodayAGAlberto Goday
- Tatiana DillaTDTatiana Dilla
- 1 June 2011
- journal article
- research article
- Published by Elsevier in Endocrinología y Nutrición
- Vol. 58 (6) , 274-282
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in SpainActa Diabetologica, 2009
- Health Care and Productivity Costs Associated With Diabetic Patients With Macrovascular Comorbid ConditionsDiabetes Care, 2009
- Using Costs in Cost-Effectiveness Models for Chronic DiseasesMedical Care, 2009
- Resource utilisation and costs for the treatment of diabetes in the developed world: an economical burden that needs to be solvedInternational Journal Of Clinical Practice, 2009
- Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED studyCurrent Medical Research and Opinion, 2009
- Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargineCurrent Medical Research and Opinion, 2009
- Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study*Current Medical Research and Opinion, 2009
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Economic cost associated with type II diabetes in Spanish patientsThe European Journal of Health Economics, 2006